BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
This Quarter Return
+6.42%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$82.2M
AUM Growth
–
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$70.5M |
| 2 |
ADMA Biologics
ADMA
|
$11.6M |
| 3 |
MBVX
MABVAX THERAPEUTICS HLDGS INC
MBVX
|
$136K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 14.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $70.5M | 85.76% |
+1,602,562
| New | +$70.5M |
|
|
2
ADMA Biologics
ADMA
$4.1B
| $11.6M | 14.08% |
+1,433,304
| New | +$11.6M |
|
|
MBVX
3
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $136K | 0.17% |
+197,641
| New | +$136K |
|